Agevisa/PB Takes Action to Combat Smoking in Paraiba Region

Sep.01.2022
Agevisa/PB Takes Action to Combat Smoking in Paraiba Region
Brazil's Agevisa reinforces actions against smoking in Paraíba and emphasizes partnerships for health protection and environmental sustainability.

The Brazilian National Health Surveillance Agency (Agevisa) has been strengthening its actions and partnerships aimed at combating smoking in the Paraiba region throughout the year. On August 29th (National Day to Combat Tobacco), General Director Geraldo Moreira de Menezes outlined measures that not only aim to educate the public about the serious harm caused by tobacco products but also to train collaborating organizations to better protect human health and the state's environment.


He emphasized the importance of establishing partnerships between the State Health Surveillance Agency, Procon/PB, the Public Department, state and federal police, Sudema/PB, the Federal Revenue Service, and other state health agencies (members of this structure). This Agency has been providing advice on the implementation and execution of a quality management system for Agevisa/PB, which has yielded very positive results. The improvement of this Agency's activities in promoting and protecting human health in Paraíba has been positively impacted.


From August 22 to 25, Agevisa/PB actively participated in a training program on tobacco control legislation and inspection for health supervisors and Procons professionals in Paraiba. The event was held online and was co-organized by the National Cancer Institute (Inca), the National Health Surveillance Agency (Anvisa), and the Pan American Health Organization (PAHO).


Helena Teixeira de Lima Barbosa, the Technical Director of Agevisa/PB's Medical Science and Technology and Related department, discussed the role of health monitoring in tobacco control. She focused on the responsibilities and challenges facing regulators and highlighted the importance of societal awareness and participation in the fight against smoking. In her speech, Helena discussed Paraiba's health surveillance actions, responsibilities, legal documents, and experiences in combating smoking. She emphasized the extreme damage to health and the environment caused by the many substances in tobacco products, including electronic cigarette devices, also known as e-cigarettes.


According to Geraldo Moreira, this year Agevisa/PB has also promoted tobacco product inspection training for coordinators and municipal health inspectors to expand and improve the promotion and protection of public health in the region.


On June 14th and 15th, training was held for public health surveillance professionals in National Health Zones 1, 12, and 14. On March 30th, a training session was conducted for Visas staff from various cities in the second health zone during an event in Guarabira/PB.


Sustainability and tobacco control - Agevisa/PB is also actively involved in the National Cancer Institute's technical visit program to Paraiba to introduce sustainable tobacco control projects. From June 27th to July 1st, 2022, representatives from INCA, PAHO, the Secretary of State, and the Municipal Health Secretary discussed the project, Agevisa/PB, Empresa Paraibana de Turismo (PBTur), and tourism in the capital of Paraiba at the Casa de Jose Americo Foundation in João Pessoa/PB.


Geraldo Moreira de Menezes, the director general of Agevisa/PB, attended the event and emphasized the state government's commitment to expanding efforts to combat smoking in Paraiba. He discussed the agency's responsibility for oversight and education, and pointed out their concerns about the growth of smoking, including hookah and e-cigarettes.


Confiscation of electronic cigarettes - as part of a permanent effort to combat smoking in Paraiba, the director of Agevisa/PB emphasized on the 29th that the working group, which was launched on June 30th in João Pessoa/PB, seized a large number of electronic smoking devices at a tobacco store near Tambau. The owner of the establishment was arrested at the time and taken to the Federal Police Headquarters for questioning.


Késsia Liliana, the head of Procon/PB, Hugo José de Barros Franca, the health technology director, and Ado Augusto Bezerra de Brito, the health risk inspection and control technology manager from Agevisa attended this operation. PB, Procon inspectors, and federal police agent Geraldo Moreira announced an intensified inspection and imposed sanitary penalties on those responsible for public or private collective-use environments allowing the use of electronic cigarettes, vaporizers, vapes, and e-cigarettes throughout the state of Paraiba. The use of cigarettes, electronic cigarettes, e-cigarettes, or any other electronic smoking device (DEF) is prohibited in environments under their responsibility.


According to Geraldo Moreira, the initiative of Law 12,351/2022 aims to strengthen Paraiba's struggle against smoking by creating a smoke-free environment for collective use, considering whether Law 1 originated from smoke.


Disclaimer: 1. The content of this article is compiled from third-party information and is only for industry exchange and learning purposes. 2. This article does not represent the views of 2FIRSTS, and 2FIRSTS is also unable to confirm the truthfulness and accuracy of the content. The compile of this article is only for industry exchange and research purposes. 3. Due to the limited compilation level, the compiled article may not express the same meaning as the original, please refer to the original article for accuracy. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, and foreign expressions and positions, 2FIRSTS maintains full consistency with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
FDA Revises Import Alert 98-07 Rules, Bringing May Enforcement Priorities Into Unauthorized ENDS Detentions
The U.S. Food and Drug Administration has revised the rules under Import Alert 98-07 to incorporate its May 2026 enforcement-priority policy for certain electronic nicotine delivery systems marketed without premarket authorization. The alert continues to allow detention without physical examination, or DWPE, for ENDS lacking required marketing authorization, while directing field divisions to apply the May risk-based framework. When necessary, detention or refusal decisions must also undergo review by the FDA's Center for Tobacco Products. Products including PACHA and Vuse Pro have already emerged as industry examples of the May policy, although enforcement discretion does not constitute FDA marketing authorization.
News
Sep.28 by 2Firsts Perspectives
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
DATA|UK Retail Research Group IGD Says Convenience Tobacco and Vape Sales Fell 10.6%, With 15.4% Market Share Versus Alcohol's 15.1%; Top Rank at Risk in 2027
Combined tobacco and vaping sales in UK convenience stores fell 10.6% year over year in the first half of 2026, making the category a major drag on channel performance, according to retail research organization IGD. Total convenience sales declined 1.2%, while sales excluding tobacco and vaping increased 0.7%. IGD's 2026 category-share figures show tobacco and vaping accounting for 15.4% of convenience sales, compared with 15.1% for alcohol. The organization forecasts alcohol could overtake tobacco and vaping as the largest category by sales value as early as 2027 if current trends continue. IGD expects the convenience market to increase from £48.6 billion in 2026 to £54.9 billion in 2031, a 2.5% compound annual growth rate, or 3.4% excluding tobacco and vaping.
DATA
Nov.11
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin Vape Directory One Year On: Retailer Reports Four Store Closures and 70% Staff Cuts
Wisconsin's electronic vaping device directory has been fully enforced for more than a year, and local vape retailers say the reduced range of eligible products has contributed to declining sales, store closures and layoffs. Johnny Vapes owner Ben Hall said he has closed four of seven locations and cut about 70% of his staff. State law bars the sale of vaping devices not listed on the Wisconsin Department of Revenue directory and allows penalties of $1,000 per day for each unlisted device sold or offered for sale. In April 2026, the U.S. Court of Appeals for the Seventh Circuit allowed enforcement of the law to continue.
Regulations
Oct.10
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22